open access

Vol 78, No 6 (2010)
ORIGINAL PAPERS
Published online: 2010-10-29
Submitted: 2013-02-22
Get Citation

Prevalence of home mechanical ventilation in Poland

Jacek Nasiłowski, Zbigniew Szkulmowski, Marek Migdał, Witalij Andrzejewski, Wojciech Drozd, Małgorzata Czajkowska-Malinowska, Andrzej Opuchlik, Ryszarda Chazan
Pneumonol Alergol Pol 2010;78(6):392-398.

open access

Vol 78, No 6 (2010)
ORIGINAL PAPERS
Published online: 2010-10-29
Submitted: 2013-02-22

Abstract


Introduction: Home mechanical ventilation (HMV) is increasingly used in the treatment of chronic respiratory failure thanks to rapid technological development, increasing number of elderly people and extension of indications. The aim of the study was to assess: prevalence of HMV in Poland, the proportions of lung disease and neuromuscular patients using HMV and the type of interface (invasive v. non-invasive).
Material and methods: The questionnaire was send to all institutions providing HMV in Poland and to regional departments of National Health System (NHS).
Results: All NHS departments responded. They reported 846 HMV users, 31% of children. The prevalence of HMV in Poland was assessed as 2,2 patient per 100.000 population without striking differences between provinces. Among 39 HMV centers in Poland 12 (31%) answered. They reported 206 patients (24% of all HMV users). Proportion of ventilation mode consisted of 59% (122 pts) treated via a tracheostomy and 41% (84 pts) with non invasive ventilation (NIV). 168 patients (82%) had neuromuscular diseases (ND), majority of them muscular dystrophy - 57 patients ( 34% of ND) and amyotrophic lateral sclerosis - 39 patients (23% of ND). There were only 38 patients (18%) with lung and thoracic cage diseases: 17 with COPD and 10 with kyphoscoliosis.
Conclusions: The prevalence of HMV treatment in Poland has developed dramatically in the last decade, but is still very low comparing to other European countries, especially due to very low number of patients with lung and chest wall diseases. The prevalence of invasive mode of ventilation is extremely high. The most important factors which inhibit development of HMV in Poland are: omission of respiratory physicians in the process of qualification, lack of national guidelines, sophisticated demands for HMV providers. The awareness of the need of HMV especially in patients with respiratory failure due to obesity hypoventilation syndrome and restrictive lung diseases should be increased among chest physicians.
Pneumonol. Alergol. Pol. 2010; 78, 6: 392-398

Abstract


Introduction: Home mechanical ventilation (HMV) is increasingly used in the treatment of chronic respiratory failure thanks to rapid technological development, increasing number of elderly people and extension of indications. The aim of the study was to assess: prevalence of HMV in Poland, the proportions of lung disease and neuromuscular patients using HMV and the type of interface (invasive v. non-invasive).
Material and methods: The questionnaire was send to all institutions providing HMV in Poland and to regional departments of National Health System (NHS).
Results: All NHS departments responded. They reported 846 HMV users, 31% of children. The prevalence of HMV in Poland was assessed as 2,2 patient per 100.000 population without striking differences between provinces. Among 39 HMV centers in Poland 12 (31%) answered. They reported 206 patients (24% of all HMV users). Proportion of ventilation mode consisted of 59% (122 pts) treated via a tracheostomy and 41% (84 pts) with non invasive ventilation (NIV). 168 patients (82%) had neuromuscular diseases (ND), majority of them muscular dystrophy - 57 patients ( 34% of ND) and amyotrophic lateral sclerosis - 39 patients (23% of ND). There were only 38 patients (18%) with lung and thoracic cage diseases: 17 with COPD and 10 with kyphoscoliosis.
Conclusions: The prevalence of HMV treatment in Poland has developed dramatically in the last decade, but is still very low comparing to other European countries, especially due to very low number of patients with lung and chest wall diseases. The prevalence of invasive mode of ventilation is extremely high. The most important factors which inhibit development of HMV in Poland are: omission of respiratory physicians in the process of qualification, lack of national guidelines, sophisticated demands for HMV providers. The awareness of the need of HMV especially in patients with respiratory failure due to obesity hypoventilation syndrome and restrictive lung diseases should be increased among chest physicians.
Pneumonol. Alergol. Pol. 2010; 78, 6: 392-398
Get Citation

Keywords

home mechanical ventilation; prevalence; noninvasive ventilation; chronic respiratory failure

About this article
Title

Prevalence of home mechanical ventilation in Poland

Journal

Advances in Respiratory Medicine

Issue

Vol 78, No 6 (2010)

Pages

392-398

Published online

2010-10-29

Bibliographic record

Pneumonol Alergol Pol 2010;78(6):392-398.

Keywords

home mechanical ventilation
prevalence
noninvasive ventilation
chronic respiratory failure

Authors

Jacek Nasiłowski
Zbigniew Szkulmowski
Marek Migdał
Witalij Andrzejewski
Wojciech Drozd
Małgorzata Czajkowska-Malinowska
Andrzej Opuchlik
Ryszarda Chazan

References (25)
  1. Dalziel J. On sleep and apparatus for promoting artificial respiration. Br Assoc Adv Sci. 1938; 2: 127.
  2. Colice GL. Historical perspective on the development of mechanical ventilation. In: Tobin MJ. ed. Principles and practice of mechanical ventilation. McGraw-Hill, New York 2006.
  3. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981; 1(8225): 862–865.
  4. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J. 2005; 25(6): 1025–1031.
  5. zarządzenie Prezesa NFZ nr 84/2009/DSOZ. www.nfz.gov.pl (07.03.2010).
  6. Ciałkowska-Rysz A. Sytuacja i wyzwania opieki paliatywnej w Polsce. Med Paliat. 2009; 1: 22–26.
  7. Simonds AK. Home ventilation. Eur Respir J. 2003; 22(supl. 47): 38s–46s.
  8. www.stat.gov.pl/cps/rde/xbcr/gus/PUBL_ludnosc_wg_plci_wieku_1pol2004_03_tablice.xls (17.07.2009).
  9. Escarrabill J. Organisation and delivery of home mechanical ventilation. Breathe. 2009; 6(1): 37–42.
  10. Janssens JP, Derivaz S, Breitenstein E, et al. Changing Patterns in Long-term Noninvasive Ventilation. Chest. 2003; 123(1): 67–79.
  11. Midgren B, Olofson J, Harlid R, et al. Home mechanical ventilation in Sweden, with reference to Danish experiences. Swedish Society of Chest Medicine. Respir Med. 2000; 94(2): 135–138.
  12. Clini E, Sturani C, Rossi A, et al. Rehabilitation and Chronic Care Study Group, Italian Association of Hospital Pulmonologists (AIPO). The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J. 2002; 20(3): 529–538.
  13. McEvoy RD, Pierce RJ, Hillman D, et al. Australian trial of non-invasive Ventilation in Chronic Airflow Limitation (AVCAL) Study Group. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009; 64(7): 561–566.
  14. Jäger L, Franklin KA, Midgren B, et al. Increased survival with mechanical ventilation in posttuberculosis patients with the combination of respiratory failure and chest wall deformity. Chest. 2008; 133(1): 156–160.
  15. Gustafson T, Franklin KA, Midgren B, et al. Survival of patients with kyphoscoliosis receiving mechanical ventilation or oxygen at home. Chest. 2006; 130(6): 1828–1833.
  16. Veale D, Rabec C, Labaan JP. Respiratory complications of obesity. Breathe. 2008; 4: 211–223.
  17. Pérez de Llano LA, Golpe R, Ortiz Piquer M, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest. 2005; 128(2): 587–594.
  18. Banerjee D, Yee BJ, Piper AJ, et al. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007; 131(6): 1678–1684.
  19. rozporządzenie Ministra Zdrowia. www.mz.gov.pl (07.03.2010).
  20. zarządzenie Prezesa NFZ nr 96/DSOZ/2008, § 15. www.nfz.gov.pl (07.03.2010).
  21. Migdał M, Szreter T, Blasiak R, et al. Program leczenia domowego dzieci z przewlekłą niewydolnością oddechową. Standardy Med. 2002; 4: 232–237.
  22. Migdał M, Jarymowicz T, Kalbowiak J, et al. Przewlekła wentylacja dzieci w warunkach domowych. Standardy Med. 2007; 4: 376–378.
  23. załącznik nr 3 do Zarządzenia Prezesa NFZ nr 84/DSOZ/2009. www.nfz.gov.pl (07.03.2010).
  24. www.codage.ext.cnamts.fr (09.01.2008).
  25. Chatwin M, Heather S, Hanak A, et al. Analysis of home support and ventilator malfunction in 1,211 ventilator-dependent patients. Eur Respir J. 2010; 35(2): 310–316.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl